Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?

Abstract

Zn(II) is an inhibitor of SARS-CoV-2′s RNA-dependent RNA polymerase, and chloroquine and hydroxychloroquine are Zn(II) ionophores–this statement gives a curious mind a lot to think about. We show results of the first clinical trials on chloroquine (CQ) and hydroxychloroquine (HCQ) in the treatment of COVID-19, as well as earlier reports on the anticoronaviral properties of these two compounds and of Zn(II) itself. Other FDA-approved Zn(II) ionophores are given a decent amount of attention and are thought of as possible COVID-19 therapeutics.

Keywords

• COVID-19
• SARS-CoV-2
• 2019-nCoV
• Zn(II) ionophores
• chloroquine
• hydroxy- chloroquine